These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 16531708)

  • 1. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
    Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
    J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy in completely resected non-small-cell lung cancer.
    Pisters KM; Le Chevalier T
    J Clin Oncol; 2005 May; 23(14):3270-8. PubMed ID: 15886314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment of early stage non-small-cell lung cancer.
    Wada H
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):102-5. PubMed ID: 10442375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 10. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
    Barlési F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
    Baumann M
    Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
    Nakajima E; Katou H
    Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
    Tiseo M; Franciosi V; Grossi F; Ardizzoni A
    Eur J Cancer; 2006 Jan; 42(1):8-16. PubMed ID: 16293409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bronchial cancer--adjuvant chemotherapy].
    Drings P
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():89-94. PubMed ID: 1983675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant chemotherapy for non-small cell lung cancer].
    Otake Y; Tanaka F; Wada H; Hitomi S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers].
    Le Chevalier T
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
    Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
    Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.